Emfret presents novel anticoagulant

BioNTech: ADC study continues with conditions

Evotec axes 400 jobs worldwide

Nitrogenases also can fix CO2

Sphingotec secures Series C financing

New antibiotic breaks resistance

Roche inks US$2bn biobucks deal with Sangamo

FDA approves cell therapy for solid tumours